Peering Into ASGN's Recent Short Interest
This United Therapeutics Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Friday
Express News | Canaccord Genuity Downgrades ASGN to Hold, Lowers Price Target to $55
William Blair Maintains ASGN Inc(ASGN.US) With Buy Rating
Truist Financial Maintains ASGN Inc(ASGN.US) With Buy Rating
UBS Maintains ASGN Inc(ASGN.US) With Sell Rating, Cuts Target Price to $54
Why ASGN (ASGN) Shares Are Sliding Today
ASGN Shares Are Trading Lower After the Company Reported a Q1 Adjusted EPS Miss and Issued Q2 EPS and Adjusted EPS Guidance Below Estimates. Additionally, UBS Cut Its Price Target on the Stock From $56 to $54.
Sector Update: Tech Stocks Gain Thursday Afternoon
ASGN Analyst Ratings
Gold Gains 1%; Bristol Myers Squibb Posts Upbeat Results
12 Information Technology Stocks Moving In Thursday's Intraday Session
ASGN Inc. Down Over 15%, On Track for Largest Percent Decrease Since March 2020 -- Data Talk
UBS Adjusts Price Target on ASGN to $54 From $56, Maintains Sell Rating
ASGN Q1 Adjusted Earnings, Revenue Decline; Q2 Outlook Issued
Express News | ASGN Inc : Jefferies Cuts Target Price to $53 From $63
Earnings Call Summary | ASGN Inc(ASGN.US) Q1 2025 Earnings Conference
ASGN Sees $985M–$1.015B Q2 Revenue Amid TopBloc Integration and AI Growth Focus
Express News | ASGN Sees Q2 GAAP EPS $0.66-$0.78 Vs $0.92 Est
ASGN Earnings Results: $ASGN Reports Quarterly Earnings